A chatbot won’t fix your family drama, but it might help you hear what someone’s really trying to say Sign up for AI for the People, a six-week newsletter course, here Last autumn, I was pacing my ...

You call it high cholesterol. Your doctor calls it hyperlipidemia, or dyslipidemia. No matter what name you use, it's a common problem. The term covers several disorders that result in extra fats, ...

A list of the world’s most misunderstood creatures includes sharks, bats and us—at least when we talk about our careers. LinkedIn estimates one in five Americans has a job that didn’t exist in 2000.

Panelists discuss how: clinical inertia, patient apathy, and the asymptomatic nature of high cholesterol all contribute to undertreatment and poor outcomes. Panelists discuss how the LDL-C crisis ...

Women of childbearing age who have elevated lipids may be at greater risk of cardiovascular issues after pregnancy than those who don’t, new data suggest. The study of more than 8,400 matched pairs of ...

Sometimes diet and exercise are not enough to lower cholesterol levels. Many different medicine options exist, including Leqvio, which can be used alone or with other medicines to help people reach ...

Cardiovascular mortality has been increasing since 1999 among individuals with hyperlipidemia in the US, especially in the South and rural areas. The incidence of cardiovascular (CV) mortality has ...

In the United States, hyperlipidemia-related CVD mortality increased from 1999 to 2019, with elderly, Black, rural men being most affected. Hyperlipidemia-related cardiovascular disease (CVD) ...

Hypercholesterolemia is a type of hyperlipidemia, even though some use the terms interchangeably. Hyperlipidemia refers to raised levels of fats in the blood and hypercholesterolemia refers to high ...

LYON, France — The drug zodasiran (formerly ARO-ANG3), which targets the production of a liver protein, substantially lowers triglyceride and a range of lipoprotein levels in patients with mixed ...

Two new small interfering RNA (siRNA) therapeutics (both Arrowhead Pharmaceuticals), each targeting different genes involved in the regulation of triglyceride-rich lipoproteins, have been shown to be ...